Carrier Screening Market Analysis: Emerging Trends and Growth Forecast 2024-2030
MarkNtel Advisors recently published a detailed industry analysis of the Carrier Screening Market. The report covers growth trends, regional marketing strategies, challenges, opportunities, and drivers influencing the market.
Insights and Analysis
of the Carrier Screening Market (2024-2030)
The Global Carrier Screening Market size was valued at
around USD 2.09 billion in 2023 & is estimated to grow at a CAGR of around
20.7% during the forecast period, i.e., 2024–30.
Access the detailed
PDF Sample report – https://www.marknteladvisors.com/query/request-sample/carrier-screening-market.html
Global Carrier
Screening Market Opportunity:
Integration of Telehealth & Digital Health Platforms to
Offer Space for Further Growth & Expansion – The integration of telehealth
and digital health platforms presents substantial prospects for the market.
Utilizing digital technologies enhances accessibility, streamlines genetic
testing services, and fosters a patient-centric approach. Telehealth platforms
empower people, particularly those in remote or underserved regions, to avail
of carrier screening services without the necessity of visiting a physical
healthcare facility. The heightened accessibility plays a pivotal role in
catering to a wider demographic. Likewise, telehealth platforms facilitate the
delivery of preconception and prenatal care, encompassing consultations for
carrier screening. This aids individuals and couples in navigating family
planning choices and addressing genetic concerns during pregnancy. For
instance,
In 2022, Ambry Genetics, a clinical diagnostic testing
company and a subsidiary of REALM IDx, introduced a novel reproductive health
initiative driven by its CARE ProgramTM (Comprehensive Assessment Risk and
Education). This digital platform aims to improve both patient and provider
experiences by facilitating easier access to genetic education, testing,
reporting, and counseling in the realm of reproductive health.
This comprehensive program enhances family planning and
prenatal care by broadening access to carrier screening and non-invasive
prenatal testing (NIPT), aiding patients in making well-informed decisions.
It's important to note that NIPT is primarily used for screening purposes, not
for diagnosis. Moreover, digital health platforms provide continuous
post-carrier screening follow-up care. This entails virtual appointments,
surveillance of genetic risks, and crafting tailored care strategies grounded
in screening outcomes.
What segments define
the Carrier Screening market from 2024 to 2030? How do these segments
contribute to market dynamics and growth?
-By Product &
Service
-Services- Market Size & Forecast 2019-2030, (USD
Million)
-Products- Market Size & Forecast 2019-2030, (USD Million)
-By Type
-Expanded Carrier Screening- Market Size & Forecast
2019-2030, (USD Million)
-Predesigned Panel Testing- Market Size & Forecast
2019-2030, (USD Million)
-Customized Panel Testing- Market Size & Forecast
2019-2030, (USD Million)
-Targeted Disease Carrier Screening- Market Size &
Forecast 2019-2030, (USD Million)
-By Medical Condition
-Pulmonary Conditions- Market Size & Forecast 2019-2030,
(USD Million)
-Hematological Conditions- Market Size & Forecast
2019-2030, (USD Million)
-Neurological Conditions- Market Size & Forecast
2019-2030, (USD Million)
-Others- Market Size & Forecast 2019-2030, (USD Million)
-By Technology
-DNA Sequencing- Market Size & Forecast 2019-2030, (USD
Million)
-PCR- Market Size & Forecast 2019-2030, (USD Million)
-DNA Microarrays- Market Size & Forecast 2019-2030, (USD
Million)
-Others- Market Size & Forecast 2019-2030, (USD Million)
-By End-User
-Hospitals & Medical Centers- Market Size & Forecast
2019-2030, (USD Million)
-Clinical Laboratories- Market Size & Forecast
2019-2030, (USD Million)
-Fertility Clinics- Market Size & Forecast 2019-2030,
(USD Million)
-Others- Market Size & Forecast 2019-2030, (USD Million)
-By Region
-North America
-South America
-Europe
-The Middle East & Africa
-Asia-Pacific
Explore the Complete Carrier Screening Market Analysis Report –
https://www.marknteladvisors.com/research-library/carrier-screening-market.html
Who are the leading
key players shaping the Carrier Screening Market landscape?
Natera, Inc., Quest Diagnostics Incorporated, Fulgent
Genetics, Invitae Corporation, Eurofins Scientific, Opko Health, Inc., Thermo
Fisher Scientific Inc., Myriad Genetics, Inc., Illumina, Inc., Centogene N.V.,
Diasorin S.P.A., Otogenetics, Genetech, Laboratory Corporation of America
Holdings, and others
Questions Addressed
in this Study
1.What factors are driving the Carrier Screening Market
growth?
2.What are the key insights into the current trends in the Carrier
Screening Market?
3.What is the current size of the Carrier Screening Market,
and how is it projected to change in the future?
4.What is the future outlook for the Carrier Screening
Market in terms of technological advancements and market expansion?
For a Customized
Analysis Report, Just Drop Your Inquiry Here – https://www.marknteladvisors.com/query/request-customization/carrier-screening-market.html
“Market research studies from MarkNtel
Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of
the payment being successfully received, the report will be sent to your email
address.”
Why MarkNtel
Advisors?
MarkNtel Advisors is a leading research, consulting, &
data analytics firm that provides an extensive range of strategic reports on
diverse industry verticals. We deliver data to a substantial & varied
client base, including multinational corporations, financial institutions,
governments, & individuals, among others.
Our specialization in niche industries & emerging
geographies allows our clients to formulate their strategies in a much more
informed way and entail parameters like Go-to-Market (GTM), product
development, feasibility analysis, project scoping, market segmentation,
competitive benchmarking, market sizing & forecasting, & trend
analysis, among others, for 15 diverse industrial verticals.
For Media Inquiries,
Please Contact:
Call: +1 628 895
8081 | +91 120 4278433
Email: sales@marknteladvisors.com
Sales Office: 564
Prospect St, B9, New Haven, Connecticut, USA-06511
Corporate Office:
Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India
Comments
Post a Comment